Pharmaceutical companies are increasingly leveraging AI-driven synthetic personas to enhance insights and strategy, according to a recent webinar sponsored by Lumanity. The webinar featured Damian Eade, Technology Transformation Officer at Lumanity, and Stéphane Lebrat, Global Insights and Analytics Director at Takeda, who discussed how these tools convert static data into dynamic conversations.
Synthetic personas offer significant benefits across the brand and insight cycle, from enriching qualitative research to aiding local teams in interpreting segmentation and continuously testing campaign effectiveness. These interactive, evidence-backed simulations allow teams to ask nuanced questions, delve into customer motivations, and explore potential objections in a simulated environment, complementing actual customer research.
Eade explained that while traditional segmentation provides a valid, evidence-based classification system, it can often feel abstract. Personas, by contrast, add a human element, making segments memorable and actionable for teams designing experiences or planning campaigns. Lebrat emphasized the ‘game-changer’ aspect of synthetic personas, particularly for global teams, as they enable a consistent, globally translatable approach to understanding customer archetypes.
A key distinction was drawn between synthetic personas and digital twins. Digital twins are probabilistic statistical models that simulate ‘what happens if’ scenarios with numeric outputs. Synthetic personas, however, are narrative synthesis models that simulate archetypal behaviors and attitudes, providing conversational, contextual, and exploratory responses. They are more effective for understanding customer hesitations or reactions to specific messages.
Lebrat noted that synthetic personas address the ‘one-slide compression’ problem by grounding every conversational answer in cited segmentation data, publications, and research, thereby reducing speculation across global and local teams. Successful implementation of synthetic personas relies on robust segmentation inputs and disciplined usage, including clear verification of citations, avoiding leading prompts, and establishing clear global guardrails for local adaptation.
Eade underscored that synthetic personas are vital for ‘keeping insights alive’ and activating segmentations beyond initial debriefs, enabling earlier pressure testing and faster iteration. They empower local markets, sales teams, and cross-functional partners to engage with segmentation in a more usable way, even facilitating role-playing for objection handling, often in local languages.
The webinar also featured a Takeda-specific case study and a demonstration of Lumanity’s EMULaiTOR technology. Eade concluded by stressing that while synthetic personas are a powerful tool, they should not replace direct customer interaction but rather inform and enhance it, ensuring responsible deployment and human oversight.
